Company Overview:- Anondita Medicare Ltd., incorporated in 1990 and based in New Delhi, is a leading manufacturer and marketer of sexual wellness products. Its flagship brand “COBRA” is among the most recognized condom brands in India. The company operates a large-scale manufacturing facility with an installed capacity of 562 million condoms annually. Supported by modern testing and quality control systems, Anondita Medicare caters to both domestic and international markets through a wide distribution network and exports. The company holds several certifications to meet global quality and safety standards, maintaining a skilled workforce for sustainable growth.
IPO Key Details
|
Parameter |
Details |
|
IPO Subscription Opens |
August 22, 2025 |
|
IPO Subscription Closes |
August 26, 2025 |
|
Basis of Allotment |
August 28, 2025 |
|
Refund Initiation Date |
August 29, 2025 |
|
Share Credit Date |
August 29, 2025 |
|
Listing Date |
September 1, 2025 (NSE SME) |
|
Issue Size |
₹69.50 crore (fresh issue) |
|
Total Shares Offered |
48 lakh equity shares |
|
Price Band |
₹137 to ₹145 per share |
|
Minimum Lot Size |
1,000 shares |
|
Minimum Retail Investment |
₹2,74,000 (2 lots) |
|
Face Value |
₹10 per share |
|
Book Running Lead Manager |
Narnolia Financial Services Limited |
|
Registrar |
Maashitla Securities Pvt. Ltd. |
|
Market Maker |
Mansi Share & Stock Broking Pvt. Ltd. |
Financial Highlights
- Earnings
per Share (EPS) around ₹9.60 with a strong Return on Net Worth (RoNW) of
approximately 38%.
- The
company has consistently expanded its capacity and distribution footprint.
- Focus
on quality control and product innovation positions Anondita well in the
competitive healthcare segment.
Subscription & GMP (Grey Market Premium)
- The
IPO saw robust subscription levels, with retail investors contributing
strongly.
- As
of August 22, 2025, the GMP stood high at ₹65 per share, indicating
significant demand in the grey market and potential listing gains of
around 44.83% over the upper price band.
- GMP
can be volatile and investors should track the latest updates before
applying or trading.
GMP Table
|
Date |
IPO Upper Price Band (₹) |
GMP (₹) |
Estimated Listing Price (₹) |
Estimated Listing Gain (%) |
|
22-Aug-2025 |
145 |
65 |
210 |
44.83% |
|
21-Aug-2025 |
145 |
60 |
205 |
41.38% |
|
20-Aug-2025 |
145 |
55 |
200 |
37.93% |
Use of IPO Proceeds:-
Anondita Medicare intends to utilize the IPO funds to:
- Fund
working capital requirements.
- Meet
general corporate purposes.
- Invest in capital expenditure including equipment purchases for capacity expansion.
How to Apply?
- Investors
can apply through ASBA facility using net banking or UPI payment mandates
linked to their demat accounts.
- Minimum
application for retail investors is 2 lots (2,000 shares), approximately
₹2.74 lakh.
- IPO
allotment results are expected by August 28, 2025, with shares credited on
August 29.
- The official listing on NSE SME is planned for September 1, 2025.
Disclaimer :- This content is for informational purposes only and does not constitute financial advice. Please consult a qualified professional before investing.
